 Narasimhan Rajaram
Concepts (209)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spectrum Analysis | 14 | 2024 | 71 | 3.640 |
Why?
| | Oxygen | 7 | 2020 | 321 | 1.660 |
Why?
| | Optical Imaging | 7 | 2020 | 23 | 1.470 |
Why?
| | Spectrum Analysis, Raman | 4 | 2024 | 55 | 1.470 |
Why?
| | Radiation Tolerance | 3 | 2020 | 83 | 1.360 |
Why?
| | Hemoglobins | 5 | 2022 | 106 | 1.130 |
Why?
| | Tumor Microenvironment | 5 | 2022 | 223 | 1.110 |
Why?
| | Skin Neoplasms | 6 | 2022 | 487 | 1.040 |
Why?
| | Synovial Fluid | 1 | 2024 | 16 | 0.940 |
Why?
| | Spectrometry, Fluorescence | 5 | 2015 | 47 | 0.940 |
Why?
| | Oxygen Consumption | 4 | 2020 | 189 | 0.900 |
Why?
| | Oxidation-Reduction | 3 | 2020 | 317 | 0.840 |
Why?
| | Radiation-Sensitizing Agents | 2 | 2018 | 51 | 0.740 |
Why?
| | Breast | 2 | 2021 | 86 | 0.740 |
Why?
| | Heat-Shock Response | 1 | 2021 | 26 | 0.730 |
Why?
| | Radiation | 1 | 2020 | 15 | 0.720 |
Why?
| | 4-Chloro-7-nitrobenzofurazan | 4 | 2015 | 6 | 0.720 |
Why?
| | Deoxyglucose | 4 | 2015 | 36 | 0.710 |
Why?
| | Cell Line, Tumor | 14 | 2024 | 1399 | 0.700 |
Why?
| | Head and Neck Neoplasms | 3 | 2019 | 282 | 0.690 |
Why?
| | Animals | 27 | 2024 | 13173 | 0.690 |
Why?
| | Hot Temperature | 1 | 2021 | 205 | 0.680 |
Why?
| | Lung Neoplasms | 3 | 2024 | 600 | 0.630 |
Why?
| | Carcinoma, Squamous Cell | 2 | 2019 | 325 | 0.610 |
Why?
| | Biosensing Techniques | 1 | 2018 | 26 | 0.610 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 55 | 0.600 |
Why?
| | Indazoles | 1 | 2018 | 44 | 0.600 |
Why?
| | Skin | 5 | 2024 | 417 | 0.590 |
Why?
| | Mice | 19 | 2024 | 5688 | 0.590 |
Why?
| | Fluorescent Dyes | 2 | 2014 | 105 | 0.540 |
Why?
| | Epithelial Cells | 1 | 2018 | 210 | 0.540 |
Why?
| | Nephelometry and Turbidimetry | 3 | 2012 | 4 | 0.520 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 378 | 0.520 |
Why?
| | Carcinoma | 2 | 2022 | 139 | 0.510 |
Why?
| | Photometry | 3 | 2012 | 14 | 0.500 |
Why?
| | Foreign Medical Graduates | 1 | 2015 | 7 | 0.490 |
Why?
| | Health Care Sector | 1 | 2015 | 15 | 0.490 |
Why?
| | Policy | 1 | 2015 | 24 | 0.480 |
Why?
| | Models, Cardiovascular | 2 | 2013 | 21 | 0.470 |
Why?
| | Breast Neoplasms | 5 | 2018 | 1189 | 0.470 |
Why?
| | Blood Vessels | 1 | 2015 | 71 | 0.470 |
Why?
| | Algorithms | 4 | 2018 | 618 | 0.430 |
Why?
| | Glucose | 1 | 2015 | 341 | 0.410 |
Why?
| | Humans | 27 | 2024 | 50389 | 0.400 |
Why?
| | Chickens | 2 | 2024 | 110 | 0.400 |
Why?
| | Equipment Design | 6 | 2024 | 290 | 0.390 |
Why?
| | Delivery of Health Care | 1 | 2015 | 308 | 0.390 |
Why?
| | Refractometry | 2 | 2012 | 5 | 0.370 |
Why?
| | Lasers, Gas | 1 | 2010 | 7 | 0.360 |
Why?
| | Lasers, Dye | 1 | 2010 | 10 | 0.360 |
Why?
| | Mice, Nude | 5 | 2019 | 252 | 0.360 |
Why?
| | Pigments, Biological | 1 | 2010 | 1 | 0.360 |
Why?
| | Microfluidics | 1 | 2010 | 6 | 0.360 |
Why?
| | Glycolysis | 3 | 2017 | 68 | 0.360 |
Why?
| | Disease Models, Animal | 4 | 2020 | 1419 | 0.350 |
Why?
| | Colonic Neoplasms | 2 | 2022 | 158 | 0.350 |
Why?
| | Carcinoma, Basal Cell | 1 | 2010 | 36 | 0.350 |
Why?
| | Models, Biological | 2 | 2012 | 723 | 0.330 |
Why?
| | Oximetry | 2 | 2024 | 65 | 0.310 |
Why?
| | Models, Chemical | 1 | 2008 | 64 | 0.310 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2018 | 106 | 0.280 |
Why?
| | Melanins | 2 | 2024 | 24 | 0.260 |
Why?
| | Female | 16 | 2024 | 26981 | 0.240 |
Why?
| | Fiber Optic Technology | 2 | 2016 | 17 | 0.240 |
Why?
| | Microscopy, Fluorescence | 2 | 2018 | 164 | 0.240 |
Why?
| | Mammary Neoplasms, Experimental | 3 | 2018 | 121 | 0.240 |
Why?
| | Neovascularization, Pathologic | 2 | 2018 | 153 | 0.240 |
Why?
| | Leukocyte Count | 1 | 2024 | 72 | 0.230 |
Why?
| | Phantoms, Imaging | 5 | 2018 | 122 | 0.230 |
Why?
| | Arthritis, Infectious | 1 | 2024 | 46 | 0.230 |
Why?
| | Tumor Cells, Cultured | 3 | 2021 | 462 | 0.230 |
Why?
| | Skin Pigmentation | 1 | 2024 | 11 | 0.220 |
Why?
| | Fluorouracil | 2 | 2022 | 56 | 0.220 |
Why?
| | Time Factors | 2 | 2024 | 2934 | 0.220 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2020 | 213 | 0.210 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 152 | 0.200 |
Why?
| | Scattering, Radiation | 4 | 2015 | 31 | 0.190 |
Why?
| | CTLA-4 Antigen | 1 | 2021 | 23 | 0.190 |
Why?
| | Neoplasms, Second Primary | 1 | 2022 | 74 | 0.190 |
Why?
| | Poultry | 1 | 2021 | 18 | 0.180 |
Why?
| | Animal Feed | 1 | 2021 | 56 | 0.180 |
Why?
| | Reproducibility of Results | 5 | 2012 | 1201 | 0.180 |
Why?
| | Meat | 1 | 2021 | 61 | 0.180 |
Why?
| | Neoplasm Metastasis | 3 | 2022 | 235 | 0.180 |
Why?
| | Sensitivity and Specificity | 4 | 2012 | 875 | 0.180 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2020 | 184 | 0.170 |
Why?
| | Spectrophotometry | 1 | 2020 | 32 | 0.170 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2020 | 37 | 0.170 |
Why?
| | Radiotherapy | 1 | 2020 | 124 | 0.170 |
Why?
| | Mice, Inbred BALB C | 4 | 2022 | 297 | 0.170 |
Why?
| | Mitochondria, Heart | 1 | 2019 | 35 | 0.160 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 2018 | 4 | 0.150 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2018 | 60 | 0.150 |
Why?
| | Nitroimidazoles | 1 | 2018 | 15 | 0.150 |
Why?
| | NAD | 1 | 2018 | 42 | 0.150 |
Why?
| | Terahertz Imaging | 1 | 2018 | 1 | 0.150 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2018 | 35 | 0.150 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 111 | 0.150 |
Why?
| | Cancer Vaccines | 1 | 2018 | 78 | 0.150 |
Why?
| | Organometallic Compounds | 1 | 2018 | 44 | 0.150 |
Why?
| | Immunohistochemistry | 1 | 2020 | 975 | 0.150 |
Why?
| | Antineoplastic Agents | 2 | 2024 | 1178 | 0.140 |
Why?
| | Colorectal Neoplasms | 1 | 2020 | 256 | 0.140 |
Why?
| | Cytoskeleton | 1 | 2016 | 41 | 0.130 |
Why?
| | Equipment Failure Analysis | 3 | 2012 | 46 | 0.130 |
Why?
| | Heart Valves | 1 | 2016 | 24 | 0.130 |
Why?
| | Myocardium | 1 | 2019 | 444 | 0.130 |
Why?
| | Mouth | 1 | 2016 | 31 | 0.130 |
Why?
| | Muscle Contraction | 1 | 2016 | 111 | 0.130 |
Why?
| | Cell Nucleus | 1 | 2016 | 186 | 0.130 |
Why?
| | Melanoma | 2 | 2022 | 281 | 0.130 |
Why?
| | RNA, Messenger | 1 | 2019 | 1101 | 0.130 |
Why?
| | Models, Statistical | 2 | 2018 | 226 | 0.130 |
Why?
| | Blood Glucose | 2 | 2015 | 443 | 0.120 |
Why?
| | India | 1 | 2015 | 52 | 0.120 |
Why?
| | China | 1 | 2015 | 87 | 0.120 |
Why?
| | Transducers | 2 | 2012 | 20 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2018 | 634 | 0.120 |
Why?
| | Energy Metabolism | 1 | 2016 | 284 | 0.110 |
Why?
| | Sulfur Dioxide | 1 | 2013 | 3 | 0.110 |
Why?
| | Blood Volume | 2 | 2011 | 69 | 0.110 |
Why?
| | Health Education | 1 | 2015 | 153 | 0.110 |
Why?
| | Regional Blood Flow | 1 | 2013 | 107 | 0.110 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2013 | 51 | 0.110 |
Why?
| | Diagnostic Imaging | 2 | 2011 | 179 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 1160 | 0.100 |
Why?
| | Kinetics | 1 | 2013 | 635 | 0.100 |
Why?
| | Molecular Imaging | 1 | 2012 | 54 | 0.100 |
Why?
| | Glycerol | 1 | 2011 | 15 | 0.100 |
Why?
| | Computer Simulation | 2 | 2012 | 284 | 0.100 |
Why?
| | Sclera | 1 | 2011 | 5 | 0.090 |
Why?
| | Choroid | 1 | 2011 | 14 | 0.090 |
Why?
| | Skin Temperature | 1 | 2011 | 15 | 0.090 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 406 | 0.090 |
Why?
| | Body Temperature | 1 | 2011 | 65 | 0.090 |
Why?
| | Middle Aged | 2 | 2024 | 12460 | 0.090 |
Why?
| | Neoplasms | 1 | 2020 | 1237 | 0.090 |
Why?
| | Adenocarcinoma | 1 | 2014 | 402 | 0.090 |
Why?
| | Microvessels | 1 | 2010 | 30 | 0.090 |
Why?
| | Epithelium | 1 | 2010 | 65 | 0.090 |
Why?
| | Artifacts | 1 | 2011 | 54 | 0.090 |
Why?
| | Computer-Aided Design | 1 | 2010 | 21 | 0.080 |
Why?
| | Immunotherapy | 2 | 2022 | 235 | 0.080 |
Why?
| | Lung | 1 | 2013 | 512 | 0.080 |
Why?
| | Male | 4 | 2024 | 25718 | 0.080 |
Why?
| | Pilot Projects | 1 | 2010 | 704 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 934 | 0.070 |
Why?
| | Brain | 1 | 2013 | 1313 | 0.060 |
Why?
| | Buthionine Sulfoximine | 1 | 2024 | 13 | 0.060 |
Why?
| | Carboplatin | 1 | 2024 | 51 | 0.060 |
Why?
| | Cisplatin | 1 | 2024 | 275 | 0.050 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2024 | 318 | 0.050 |
Why?
| | Light | 2 | 2012 | 70 | 0.050 |
Why?
| | Mice, Inbred A | 1 | 2020 | 15 | 0.040 |
Why?
| | Healthcare Disparities | 1 | 2024 | 279 | 0.040 |
Why?
| | Precancerous Conditions | 1 | 2020 | 83 | 0.040 |
Why?
| | Phenotype | 1 | 2022 | 736 | 0.040 |
Why?
| | Mice, Obese | 1 | 2019 | 20 | 0.040 |
Why?
| | Macrophages | 1 | 2022 | 363 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2019 | 88 | 0.040 |
Why?
| | Down-Regulation | 1 | 2019 | 343 | 0.040 |
Why?
| | Gene Deletion | 1 | 2018 | 267 | 0.040 |
Why?
| | Disease Progression | 1 | 2020 | 823 | 0.030 |
Why?
| | Tooth Apex | 1 | 2016 | 1 | 0.030 |
Why?
| | Optical Fibers | 1 | 2016 | 8 | 0.030 |
Why?
| | Body Weight | 1 | 2019 | 514 | 0.030 |
Why?
| | Shear Strength | 1 | 2016 | 9 | 0.030 |
Why?
| | Cell Size | 1 | 2016 | 46 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2024 | 2780 | 0.030 |
Why?
| | Stress, Mechanical | 1 | 2016 | 92 | 0.030 |
Why?
| | Keratinocytes | 1 | 2016 | 91 | 0.030 |
Why?
| | Infant | 1 | 2024 | 3601 | 0.030 |
Why?
| | Child, Preschool | 1 | 2024 | 3908 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2014 | 84 | 0.030 |
Why?
| | Aging | 1 | 2019 | 675 | 0.030 |
Why?
| | Halogenation | 1 | 2013 | 4 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 1785 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2013 | 62 | 0.030 |
Why?
| | Iodine Radioisotopes | 1 | 2013 | 36 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 69 | 0.030 |
Why?
| | Blood Flow Velocity | 1 | 2013 | 100 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2013 | 75 | 0.030 |
Why?
| | Aerobiosis | 1 | 2013 | 14 | 0.030 |
Why?
| | Isotope Labeling | 1 | 2013 | 53 | 0.030 |
Why?
| | Mice, SCID | 1 | 2013 | 173 | 0.030 |
Why?
| | Rats, Nude | 1 | 2012 | 2 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2016 | 1589 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 113 | 0.030 |
Why?
| | Young Adult | 2 | 2014 | 4064 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2012 | 82 | 0.030 |
Why?
| | Diffusion | 1 | 2011 | 15 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2012 | 86 | 0.020 |
Why?
| | Optical Phenomena | 1 | 2011 | 10 | 0.020 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2011 | 11 | 0.020 |
Why?
| | Osmolar Concentration | 1 | 2011 | 63 | 0.020 |
Why?
| | Eye | 1 | 2011 | 24 | 0.020 |
Why?
| | Cricetinae | 1 | 2011 | 211 | 0.020 |
Why?
| | Obesity | 1 | 2019 | 1125 | 0.020 |
Why?
| | Pressure | 1 | 2011 | 105 | 0.020 |
Why?
| | Models, Animal | 1 | 2011 | 228 | 0.020 |
Why?
| | Rabbits | 1 | 2011 | 375 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 396 | 0.020 |
Why?
| | Swine | 1 | 2011 | 408 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2018 | 5230 | 0.020 |
Why?
| | Adult | 2 | 2014 | 13568 | 0.020 |
Why?
| | Rats | 1 | 2012 | 3287 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2014 | 3180 | 0.020 |
Why?
| | Aged | 1 | 2014 | 9590 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 6475 | 0.010 |
Why?
|
|
Rajaram's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|